|
1
|
Fidelity Investments
Boston,
Massachusetts
|
$152M
|
+$2.32M
|
+149,533
|
+2%
|
|
|
2
|
|
$107M
|
–
|
–
|
–
|
|
|
3
|
Decheng Capital
Menlo Park,
California
|
$61.8M
|
–
|
–
|
–
|
|
|
4
|
|
$49M
|
+$7.88M
|
+507,200
|
+24%
|
|
|
5
|
Enavate Sciences
Menlo Park,
California
|
$46.3M
|
–
|
–
|
–
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$45.9M
|
+$4.22M
|
+271,718
|
+13%
|
|
|
7
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$45.9M
|
–
|
–
|
–
|
|
|
8
|
TCG Crossover Management
Palo Alto,
California
|
$39.8M
|
-$10.6M
|
-684,660
|
-24%
|
|
|
9
|
Altshuler Shaham
Tel Aviv,
Israel
|
$26.7M
|
-$30.7M
|
-1,977,619
|
-58%
|
|
|
10
|
Omega Fund Management
Boston,
Massachusetts
|
$25.5M
|
-$10.6M
|
-680,000
|
-33%
|
|
|
11
|
|
$22M
|
-$17.5M
|
-1,126,021
|
-49%
|
|
|
12
|
Wellington Management Group
Boston,
Massachusetts
|
$21.2M
|
-$1.55M
|
-99,900
|
-8%
|
|
|
13
|
State Street
Boston,
Massachusetts
|
$21M
|
+$9.84M
|
+633,206
|
+132%
|
|
|
14
|
Samsara BioCapital
Palo Alto,
California
|
$18.1M
|
-$7.47M
|
-481,077
|
-33%
|
|
|
15
|
Marshall Wace
London,
United Kingdom
|
$16.3M
|
+$8.97M
|
+577,473
|
+199%
|
|
|
16
|
Parkman Healthcare Partners
Stamford,
Connecticut
|
$15.9M
|
+$1.99M
|
+127,998
|
+18%
|
|
|
17
|
Geode Capital Management
Boston,
Massachusetts
|
$15.4M
|
+$2.65M
|
+170,474
|
+26%
|
|
|
18
|
Siren LLC
Greenwich,
Connecticut
|
$14.8M
|
–
|
–
|
–
|
|
|
19
|
Woodline Partners
San Francisco,
California
|
$11.3M
|
+$684K
|
+44,000
|
+8%
|
|
|
20
|
Nantahala Capital Management
New Canaan,
Connecticut
|
$11.2M
|
–
|
–
|
–
|
|
|
21
|
Integral Health Asset Management
New York
|
$10.8M
|
+$8.93M
|
+575,000
|
New
|
|
|
22
|
Great Point Partners
Greenwich,
Connecticut
|
$5.64M
|
–
|
–
|
–
|
|
|
23
|
Charles Schwab
San Francisco,
California
|
$5.36M
|
+$1.66M
|
+106,575
|
+60%
|
|
|
24
|
UBS Group
Zurich,
Switzerland
|
$5.12M
|
+$612K
|
+39,384
|
+17%
|
|
|
25
|
Northern Trust
Chicago,
Illinois
|
$4.79M
|
+$395K
|
+25,416
|
+11%
|
|
